Claims Appeals banner - coverage Access support

Coverage & Access Support

The instructions below will help you get started. Click the “Forms & Resources” tab above to find more forms and information.

Logo for Injectafer(R) (ferric carboxymaltose injection)

Injectafer coverage access tabs

Billing and Coding

Code Description
Product package code
NDC 0517-0602-01 Injectafer (ferric carboxymaltose injection) 100 mg iron/2 mL single-use vial (individually boxed)
NDC 00517-0650-01 Injectafer (ferric carboxymaltose injection) 750 mg iron/15 mL single-use vial (individually boxed)
Product-specific billing code
HCPCS J1439 Injection, ferric carboxymaltose, 1 mg
Drug administration codes
CPT®* 96374


Therapeutic, prophylactic, or diagnostic injection (specify substance or drug) Intravenous push single or initial substance drug

Intravenous infusion for therapy, prophylaxis, or diagnosis (specify substance or drug); initial up to 1 hr
*CPT® codes, copyright 2023 American Medical Association (AMA). All rights reserved. CPT is a trademark of the AMA. No fee schedules, basic units, relative values, or related listings are included in the CPT. The AMA assumes no liability for the data contained herein. Applicable FARS/DFARS restrictions apply to government use.

CPT, Current Procedural Terminology; FARS/DFARS, Federal Acquisition Regulation/Defense Federal Acquisition Regulation Supplement; HCPCS, Healthcare Common Procedure Coding System; NDC, National Drug Code.

We recommend verifying the coding policies for each individual health plan. Access Central Coordinators can provide information relating to payer-specific policies and can address other questions at 1-866-4-DSI-NOW.

Examples of ID/IDA-related diagnosis codes

Injectafer claims forms require an appropriate ICD-10-CM code. The following table displays possible ICD-10-CM codes related to ID/IDA.*

Primary diagnosis codes (ICD-10-CM)
D50.0 Iron deficiency anemia secondary to blood loss (chronic)
D50.1 Sideropenic dysphagia
D50.8 Other iron deficiency anemias
D50.9 Iron deficiency anemia, unspecified
E61.1 Iron deficiency (excludes iron deficiency anemia)
D63.0 Anemia in neoplastic disease
CODE NEOPLASM FIRST (Confirm iron deficiency)
D63.1 Anemia in chronic kidney disease
CODE CKD STAGE FIRST (Confirm iron deficiency)
D63.8 Anemia in other chronic diseases
classified elsewhere CODE UNDERLYING DISEASE FIRST (Confirm iron deficiency)
D63.81 Antineoplastic chemotherapy-induced anemia (Confirm iron deficiency)

Other codes may be appropriate.

Coding for Injectafer is dependent on the insurer and the care setting in which the drug will be administered. These tables are provided for informational purposes only, and you have the responsibility to ensure that claims and codes submitted are accurate, complete, and applicable. Healthcare providers need to make coding decisions based on the diagnosis and treatment of each patient and the specific insurer. Please visit or other payers’ websites to obtain additional guidance on their processes.

A code specific for your IDA patient’s underlying condition

The following table displays possible ICD-10-CM codes that may be appropriate for patients prescribed Injectafer.*

Codes related to IDA patient’s underlying condition (ICD-10-CM)
K50.0-K50.919 Crohn's disease [regional enteritis]
K51.0-K51.919 Ulcerative colitis
K90.0 Celiac disease
K90.4 Malabsorption due to intolerance not elsewhere classified
K90.9 Intestinal malabsorption unspecified
N18.1 Chronic kidney disease, stage 1
N18.2 Chronic kidney disease, stage 2
N18.30 Chronic kidney disease stage 3 unspecified
N18.31 Chronic kidney disease stage 3a
N18.32 Chronic kidney disease stage 3b
N18.4 Chronic kidney disease, stage 4
N18.5 Chronic kidney disease, stage 5
N18.6 End-stage renal disease
N18.9 Chronic kidney disease, unspecified
N92.0 Excessive and frequent menstruation with regular cycle
N92.5 Other specified irregular menstruation
N92.6 Irregular menstruation, unspecified
T45.4X5A Adverse effect of iron and its compounds, initial encounter
T50.905A Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
A code for your patient with ID in HF

The following table displays possible ICD-10-CM codes that may be appropriate for patients prescribed Injectafer.*

I09.81 Rheumatic heart failure
I11.0 Hypertensive heart disease with heart failure
I50 Heart failure
I50.1 Left ventricular failure, unspecified
I50.2 Systolic (congestive) heart failure
I50.20 Unspecified systolic (congestive) heart failure
I50.21 Acute systolic (congestive) heart failure
I50.22 Chronic systolic (congestive) heart failure
I50.23 Acute on chronic systolic (congestive) heart failure
I50.3 Diastolic (congestive) heart failure
I50.30 Unspecified diastolic (congestive) heart failure
I50.31 Acute diastolic (congestive) heart failure
I50.32 Chronic diastolic (congestive) heart failure
I50.33 Acute on chronic diastolic (congestive) heart failure
I50.4 Combined systolic and diastolic (congestive) heart failure
I50.40 Unspecified combined systolic and diastolic (congestive) heart failure
I50.41 Acute combined systolic and diastolic (congestive) heart failure
I50.42 Chronic combined systolic and diastolic heart failure
I50.43 Acute on chronic combined systolic and diastolic heart failure
I50.8 Other heart failure
I50.81 Right heart failure
I50.810 Right heart failure, unspecified
I50.811 Acute right heart failure
I50.812 Chronic right heart failure
I50.813 Acute on chronic right heart failure
I50.814 Right heart failure due to left heart failure
I50.82 Biventricular heart failure
I50.83 High output heart failure
I50.84 End stage heart failure
I50.89 Other heart failure
I50.9 Heart failure, unspecified

*A joint effort between the healthcare provider and the coder is essential to achieve complete and accurate documentation, code assignment, and reporting of diagnoses and procedures. This information is provided to assist both the healthcare provider and the coder in identifying potential diagnoses. The importance of consistent, complete documentation in the medical record cannot be overemphasized. Without such documentation, accurate coding cannot be achieved. The entire record should be reviewed to determine the specific reason for the encounter and the conditions treated.

Secondary code suggestions only; appropriate codes not limited to those listed above. Injectafer is indicated to treat ID in adult patients with HF and NYHA II/III; it is not indicated to treat the above-listed underlying conditions. Some listed diagnosis codes may indicate a subcategory and be nonbillable. For reporting purposes, only codes with the full number of required characters are permissible.

HF, heart failure; ICD-10-CM, International Classification of Diseases, Tenth Revision, Clinical Modification; ID, iron deficiency; IDA, iron deficiency anemia; NYHA, New York Heart Association.

We recommend verifying the coding policies for each individual health plan. Reimbursement specialists can provide information relating to payer-specific policies and can address other questions at 1-866-4-DSI-NOW.

The completion and submission of coverage- or reimbursement-related documentation are the responsibility of the patient and healthcare provider. Daiichi Sankyo, Inc., makes no representation or guarantee concerning coverage or reimbursement for any service or item. A completed form includes signatures from both the physician and the patient. Before submitting, please ensure all required information is provided.